# A Study of Ninlaro in Real World Clinical Practice in China

> **NCT04328662** · — · COMPLETED · sponsor: **Takeda** · enrollment: 482 (actual)

## Conditions studied

- Multiple Myeloma
- Neoplasms, Plasma Cell

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT04328662
- **Lead sponsor:** Takeda
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2020-05-18
- **Primary completion:** 2026-02-13
- **Final completion:** 2026-02-13
- **Target enrollment:** 482 (ACTUAL)
- **Last updated:** 2026-03-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04328662

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04328662, "A Study of Ninlaro in Real World Clinical Practice in China". Retrieved via AI Analytics 2026-07-02 from https://api.ai-analytics.org/clinical/NCT04328662. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*